Cell Culture Technology– category –
-
Lonza Unveils Rapid Custom Media Prototyping Service (RaMP) to Drastically Accelerate Early Bioprocess Development Timelines
Outsourced Pharma Global Overview Lonza has launched its Rapid Media Prototyping Service (RaMP) to significantly shorten early bioprocess development timelines for biopharmaceutical companies. This service provides custom liquid and powd... -
FDA Expands Regulatory Flexibility for Cell and Gene Therapies, Streamlining CMC Requirements to Accelerate Early Clinical Development
Medicinova, Inc. (Facebook) USA Overview The US FDA has announced an expansion of regulatory flexibility for Cell and Gene Therapy (CGT) products, particularly adapting Chemistry, Manufacturing, and Controls (CMC) requirements across the... -
Japan Establishes Global Trust and Safety in Stem Cell Therapy Through Rigorous Act on the Safety of Regenerative Medicine (ASRM)
Grand Green Osaka Umekita Clinic Japan Overview Japan has solidified its position as a globally trusted nation for regenerative medicine, including stem cell therapy, through the 2014 Act on the Safety of Regenerative Medicine (ASRM). Th... -
Upside Foods Withdraws $50M Bid for Believer Meats’ US Facility, Signaling Strategic Re-evaluation Amidst Industry Consolidation
AgFunderNews USA Overview US cultivated meat startup Upside Foods has withdrawn its $50 million bid to acquire the shuttered North Carolina facility of former competitor Believer Meats, yet confirmed its continued interest. The facility ... -
AI Transforms Hematopoietic Stem Cell Research: Digital Twins and Reinforcement Learning Applied from Disease Modeling to Industrial CAR-T Cell Manufacturing
Baishideng Publishing Group Global Overview Artificial Intelligence (AI) shows vast potential in hematopoietic stem cell (HSC) research and related malignancies, spanning from disease modeling to cell manufacturing. Notably, digital twin... -
Asia, Led by Japan, Emerges as Global Clinical Research Hub, Fueled by Government Investment in Regenerative Medicine and Advanced Biomanufacturing
GlobalData Japan Overview Asia, particularly Japan, is rapidly emerging as a global hub for clinical research innovation. Japan ranked among the top 5 countries globally for clinical trial growth between Q2 2024 and Q2 2025. This signifi... -
Integration of Digital Twins, AI, PAT, and IoT Revolutionizes Single-Use Mixing Solutions in Bioprocess Engineering for Enhanced Robustness
Facebook Global Overview In bioprocess engineering, the selection of single-use mixing solutions is significantly advanced by integrating digital twin technology, AI/machine learning (ML), Process Analytical Technology (PAT), IoT, and so... -
Corning Life Sciences Expands Advanced 3D Cell Culture and Bioprocess Solutions, Accelerating Research and Clinical Translation
Corning USA Overview Corning Life Sciences is continuously enhancing its portfolio of 3D cell culture models, stem cell research tools, bioprocess solutions, and cell therapy products. The company's offerings aim to replicate in vivo fun... -
KOLON Biotech Expands Comprehensive CDMO Services in Korea, Specializing in Cell, Gene, and Exosome Therapies
MTEC South Korea Overview KOLON Biotech in South Korea is bolstering its capabilities as a specialized Contract Development and Manufacturing Organization (CDMO) for advanced cell, gene, and exosome therapies. The company offers end-to-e... -
Drastic Cost Reduction in Biosimilar Manufacturing: Integrated Strategies of Continuous Bioprocessing, QbD, Single-Use Systems, and AI
Pharma Advancement USA Overview Integrated strategies including continuous bioprocessing with high-density cell culture, Quality by Design (QbD) with Process Analytical Technology (PAT), single-use systems with modular facility design, a...
